In this study, we investigated the mechanism of the blood -brain barrier (BBB) transport of bunitrolol (BTL), as a model of i-blocker, in vivo and in vitro. In order to define the contribution of P-glycoprotein (P-gp) to the active efflux of BTL from brain to blood, we examined the in vivo brain dis
β¦ LIBER β¦
Contribution of P-glycoprotein to efflux of ramosetron, a 5-HT3 receptor antagonist, across the blood-brain barrier
β Scribed by Chika Yamamoto; Hideyasu Murakami; Noriko Koyabu; Hitomi Takanaga; Hirotami Matsuo; Takeshi Uchiumi; Michihiko Kuwano; Mikihiko Naito; Takashi Tsuruo; Hisakazu Ohtani; Yasufumi Sawada
- Book ID
- 111769106
- Publisher
- Pharmaceutical Press
- Year
- 2002
- Tongue
- English
- Weight
- 248 KB
- Volume
- 54
- Category
- Article
- ISSN
- 2042-7158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Contribution of P-glycoprotein to bunitr
β
Jo Matsuzaki; Chika Yamamoto; Tetsuo Miyama; Hitomi Takanaga; Hirotami Matsuo; H
π
Article
π
1999
π
John Wiley and Sons
π
English
β 143 KB
π 2 views
Active efflux of the 5-HT1A receptor ago
β
Inez C.J van der Sandt; Raquel Smolders; Lobna Nabulsi; Klaas P Zuideveld; Alber
π
Article
π
2001
π
Elsevier Science
π
English
β 244 KB
Lipophilicities of Baclofen Ester Prodru
β
Christiane Leisen; Peter Langguth; Bernd Herbert; Cornelia Dressler; Annette Kog
π
Article
π
2003
π
Springer US
π
English
β 179 KB
Restricted transport of cyclosporin A ac
β
Akira Tsuji; Ikumi Tamai; Atsushi Sakata; Yoshiyuki Tenda; Tetsuya Terasaki
π
Article
π
1993
π
Elsevier Science
π
English
β 475 KB
5 In vitro studies of S9788 as a reversi
β
L. Fenart; M. G. Poullain; B. Giroux; R. Cecchelli; M. P. Dehouck
π
Article
π
1996
π
Springer
π
English
β 92 KB
Enhanced cerebral uptake of receptor lig
β
P. Doze; A. Van Waarde; P.H. Elsinga; N.H. Hendrikse;; W. Vaalburg
π
Article
π
2000
π
John Wiley and Sons
π
English
β 170 KB
π 2 views
Low cerebral uptake of some therapeutic drugs can be enhanced by modulation of P-glycoprotein (P-gp), an ATP-driven drug efflux pump at the blood-brain barrier (BBB). We investigated the possibility of increasing cerebral uptake of the beta-adrenergic ligands S-1'-[(18)F]-fluorocarazolol (FCAR) and